Trials / Unknown
UnknownNCT03793998
Catheter Ablation of Arrhythmias With High Density Mapping System in the Real World Practice.
Catheter Ablation of Arrhythmias With High Density Mapping System in the Real World Practice. The CHARISMA Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Azienda Ospedaliera Pugliese Ciaccio · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The CHARISMA study is a non-randomized, multicenter, prospective study in which consecutive patients indicated for arrhythmia will be enrolled. Patients can be treated with any market released catheter for ablation and diagnostic examination. The decision to perform the ablation will be made based on clinical evaluation of the investigators according to their clinical practice. The study does not require specific surgical techniques. The study has been designed to describe the Italian clinical practice in relation to the ablation approach of different kind of arrhythmias. In particular, the investigators will analyze the percentage of acute and long-term success in clinical practice, predictors of arrhythmias recurrence and they will describe the methods for the validation of ablation success, the techniques adopted, and the patient management approaches in the participating centers
Conditions
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2023-01-01
- Completion
- 2024-01-01
- First posted
- 2019-01-04
- Last updated
- 2019-01-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03793998. Inclusion in this directory is not an endorsement.